Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koty, P. P.
Right arrow Articles by Hoffman, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koty, P. P.
Right arrow Articles by Hoffman, E. P.
NEUROLOGY 1996;47:963-968
© 1996 American Academy of Neurology

Myotonia and the muscle chloride channel

Dominant mutations show variable penetrance and founder effect

P. P. Koty, PhD, E. Pegoraro, MD, G. Hobson, PhD, H. G. Marks, MD, A. Turel, MD, D. Flagler, MD, M. Cadaldini, MD, C. Angelini, MD and E. P. Hoffman, PhD

From the Departments of Molecular Genetics and Biochemistry, Human Genetics, and Pediatrics (Drs. Koty, Pegoraro, and Hoffman), University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Medical Cell Biology (Dr. Hobson) and Department of Neurology (Dr. Marks), A.I. duPont Institute, Wilmington, DE; Department of Neurology (Dr. Turel), Geisinger Medical Center, Danville, PA; Department of Neurology (Dr. Flagler), Borgess Medical Center, Kalamazoo, MI; and Department of Neurology (Drs. Cadaldini and Angelini), Universita degli Studi di Padova, Italy.
Supported by a grant from the National Institutes of Health (NINDS 34193).
Received August 7, 1995. Accepted in final form January 24, 1996.
Address correspondence and reprint requests to Dr. Eric P. Hoffman, BST W1211, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.

The delayed relaxation or sustained contraction of skeletal muscle-myotonia--is frequently seen in myotonic dystrophy and sodium channelopathies (hyperkalemic periodic paralysis, paramyotonia congenita). Many cases of congenital myotonia without other clinical symptoms have been associated with mutations in the muscle chloride channel gene. Most cases reported to date show a recessive inheritance pattern, with loss of function of the corresponding protein. Six families have been reported with dominantly inherited myotonia and mutations of the chloride channel gene. Here we report clinical and molecular data on 38 family members from four new families with dominantly inherited myotonia congenita. Three families show a previously characterized G230E mutation, and we show that these three share a common affected ancestor despite living in different regions of the United States (linkage disequilibrium). One Italian family is shown to have a novel dominant mutation--I290M. This is the sixth mutation identified in Thomsen's myotonia. Genotype/phenotype correlations in these four families showed that both of the dominant mutations resulted in a mild clinical picture in 90% of the patients, and no symptoms in 10% of mutation-positive patients. The EMG was the clinical feature that most closely correlated with mutation data; however, 3 of 16 (19%) mutation-positive patients tested negative by electromyography at least once, and 1 (6%) tested negative despite multiple tests. Only about half (55%) of the mutation-positive patients tested positive for percussion myotonia. Most of the clinically symptomatic individuals stated that cold temperatures and stress substantially worsened their myotonia. Our data show that dominantly inherited Thomsen's myotonia is most often a very mild disorder that shows considerable clinical heterogeneity.

NEUROLOGY 1996;47: 963-968




This article has been cited by other articles:


Home page
Exp PhysiolHome page
X. F. Wang, M. M. Reddy, and P. M. Quinton
Effects of a new cystic fibrosis transmembrane conductance regulator inhibitor on Cl- conductance in human sweat ducts
Exp Physiol, July 1, 2004; 89(4): 417 - 425.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F.-F. Wu, A. Ryan, J. Devaney, M. Warnstedt, Z. Korade-Mirnics, B. Poser, M. J. Escriva, E. Pegoraro, A. S. Yee, K. J. Felice, et al.
Novel CLCN1 mutations with unique clinical and electrophysiological consequences
Brain, November 1, 2002; 125(11): 2392 - 2407.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. J. Jentsch, V. Stein, F. Weinreich, and A. A. Zdebik
Molecular Structure and Physiological Function of Chloride Channels
Physiol Rev, April 1, 2002; 82(2): 503 - 568.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhang, M. C. Sanguinetti, H. Kwiecinski, and L. J. Ptacek
Mechanism of Inverted Activation of ClC-1 Channels Caused by a Novel Myotonia Congenita Mutation
J. Biol. Chem., January 28, 2000; 275(4): 2999 - 3005.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. Lehmann-Horn and K. Jurkat-Rott
Voltage-Gated Ion Channels and Hereditary Disease
Physiol Rev, October 1, 1999; 79(4): 1317 - 1372.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Papponen, T. Toppinen, P. Baumann, V. Myllyla, J. Leisti, H. Kuivaniemi, G. Tromp, and R. Myllyla
Founder mutations and the high prevalence of myotonia congenita in northern Finland
Neurology, July 1, 1999; 53(2): 297 - 297.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by AAN Enterprises, Inc.